Profile
Denis G.
Kay is the founder of Alpha Cognition, Inc., founded in 2000, serving as Chief Scientific Officer.
Dr. Kay is the founder of Neurodyn Life Sciences, Inc., founded in 2006, serving as Chief Scientific Officer.
Former job includes Director & Chief Scientific Officer at Neurodyn, Inc. Education includes a doctorate from McGill University and undergraduate and graduate degrees from Dalhousie University.
Denis Kay active positions
| Companies | Position | Start |
|---|---|---|
| ALPHA COGNITION INC. | Founder | 31/12/1999 |
Neurodyn Life Sciences, Inc.
Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases | Founder | 31/07/2006 |
Former positions of Denis Kay
| Companies | Position | End |
|---|---|---|
Neurodyn, Inc.
Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection | Chief Tech/Sci/R&D Officer | - |
Training of Denis Kay
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dalhousie University
Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurodyn, Inc.
Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection | Health Technology |
Neurodyn Life Sciences, Inc.
Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
- Stock Market
- Insiders
- Denis Kay
















